We found that 63.08% (41/65) of ovarian cancer cell lines from the CCLE database harbored FBP1 promoter DNA methylation and the degree of methylation was negatively correlated with the FBP1 mRNA expression level (Fig. 5A). This evidence concerns the gene FBP1 and ovarian cancer.